Typicality: | 0.376 |
Saliency: | 0.348 |
after preliminary clinical evidence | 2 | temporal |
drug → be intended to treat → serious condition | 18 |
drug → be intended to treat → serious conditions | 8 |
drug → be intended to treat → serious disease | 7 |
drug → be for → serious condition | 5 |
drug → be used to treat → serious conditions | 3 |
negative | neutral | positive |
0.100 | 0.311 | 0.590 |
Raw frequency | 41 |
Normalized frequency | 0.348 |
Modifier score | 0.700 |
Perplexity | 14.214 |